Literature DB >> 22922180

Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 2: Smoke chemistry and in vitro toxicological evaluation using smoking regimens reflecting human puffing behavior.

Volker Zenzen1, Joerg Diekmann, Birgit Gerstenberg, Susanne Weber, Sandra Wittke, Matthias K Schorp.   

Abstract

Chemical analysis of up to 49 harmful and potentially harmful constituents (HPHC) in mainstream smoke, in vitro cytotoxicity of the particulate and gas/vapor phase of mainstream smoke determined in the Neutral Red Uptake assay, and in vitro bacterial mutagenicity of the particulate phase determined in the Salmonella typhimurium Reverse Mutation (Ames) assay are reported for three Electrically Heated Cigarette Smoking System (EHCSS) series-K cigarettes, the University of Kentucky Reference Cigarette 2R4F, and a number of comparator commercial conventional lit-end cigarettes (CC) under ISO machine-smoking conditions and a total of 25 additional smoking regimens reflecting 'human puffing behavior' (HPB). The smoking machines were set to deliver nicotine yields for the EHCSS and comparator CC derived from the 10th percentile to the 90th percentile of nicotine uptake distributions in smokers determined in two clinical studies. Duplication of the smoking intensity 'per cigarette' on a smoking machine may provide an insight into product performance that is directly relevant to obtaining scientific evidence for reduced exposure substantiation based on mainstream cigarette smoke HPHC-to-nicotine regressions. The reported data support an overall evaluation of reduced exposure to HPHC and biological activity.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22922180     DOI: 10.1016/j.yrtph.2012.08.004

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  8 in total

1.  An experimental method to study emissions from heated tobacco between 100-200°C.

Authors:  Mark Forster; Chuan Liu; Martin G Duke; Kevin G McAdam; Christopher J Proctor
Journal:  Chem Cent J       Date:  2015-04-16       Impact factor: 4.215

2.  Comparison of the Pharmacokinetics of Nicotine Following Single and Ad Libitum Use of a Tobacco Heating System or Combustible Cigarettes.

Authors:  Patrick Picavet; Christelle Haziza; Nicola Lama; Rolf Weitkunat; Frank Lüdicke
Journal:  Nicotine Tob Res       Date:  2015-10-05       Impact factor: 4.244

3.  In vitro RNA-seq-based toxicogenomics assessment shows reduced biological effect of tobacco heating products when compared to cigarette smoke.

Authors:  Linsey E Haswell; Sarah Corke; Ivan Verrastro; Andrew Baxter; Anisha Banerjee; Jason Adamson; Tomasz Jaunky; Christopher Proctor; Marianna Gaça; Emmanuel Minet
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

Review 4.  Heated Tobacco Products: A Review of Current Knowledge and Initial Assessments.

Authors:  Nadja Mallock; Elke Pieper; Christoph Hutzler; Frank Henkler-Stephani; Andreas Luch
Journal:  Front Public Health       Date:  2019-10-10

5.  In vitro mutagenicity of gas-vapour phase extracts from flavoured and unflavoured heated tobacco products.

Authors:  Theo Le Godec; Ian Crooks; Ken Scott; Clive Meredith
Journal:  Toxicol Rep       Date:  2019-10-07

6.  The influencing factors of health hazards of benzo[a]pyrene in cigarette mainstream smoke: The example of one brand in Beijing.

Authors:  Junrui Chang; Qin Wang; Xiaoyan Dong; Tian Luo; Zhe Liu; Dongqun Xu
Journal:  Tob Induc Dis       Date:  2022-09-23       Impact factor: 5.163

Review 7.  Lung deposition analyses of inhaled toxic aerosols in conventional and less harmful cigarette smoke: a review.

Authors:  Clement Kleinstreuer; Yu Feng
Journal:  Int J Environ Res Public Health       Date:  2013-09-23       Impact factor: 3.390

8.  Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke.

Authors:  Pooneh Nabavizadeh; Jiangtao Liu; Christopher M Havel; Sharina Ibrahim; Ronak Derakhshandeh; Peyton Jacob Iii; Matthew L Springer
Journal:  Tob Control       Date:  2018-09-11       Impact factor: 7.552

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.